Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 29 results for "Zegerid"

As Proton Pump Inhibitor Lawsuits Mount, New Study Suggests Long-Term Use of Heartburn Drugs May Lead to Dangerous Stomach Infections, Bernstein Liebhard LLP Reports
International Business Times

As Proton Pump Inhibitor Lawsuits Mount, New Study Suggests Lo...

NEW YORK, Jan. 9, 2017 /PRNewswire/ -- As proton pump inhibitor lawsuits involving serious kidney injuries continue to mount in courts throughout the U.S, a new study suggests that long-term use of these and other heartburn medications could place ... TickerTech.com, 1 week ago
[x]  

2 images for "Zegerid"

Drug Store News, 3 months ago
Drug Store News, 6 months ago

Valeant Price Target: $0

Source Before I start, I want to make something clear: Short sellers are investors too. Shorting a stock is not immoral or evil, and it doesn't deserve the abuse it gets from longs. Investors who short stocks do so at significant risk because ...
 Seeking Alpha3 weeks ago

Janssen Sciences Ireland UC Release: Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen

CORK, Ireland , Dec.19, 2016 /PRNewswire/ --Janssen Sciences Ireland UC (Janssen) today announced that two Phase III studies to evaluate the safety and efficacy of switching virologically suppressed patients from a three or four drug (integrase ...
 BioSpace4 weeks ago Positive Results From First Phase III Studies of Investigational Two-Drug HIV Treatment Regimen  4 Traders1 month ago GLAXOSMITHKLINE : ViiV Healthcare announces positive results from first phase III studies of two-drug HIV treatment regimen  4 Traders1 month ago ViiV Healthcare announces positive results from first phase III studies of two-drug HIV treatment regimen  National AIDS Treatment Advocacy Project4 weeks ago
[x]  

GlaxoSmithKline PLC ViiV announce phase III results for 2-drug regimen

20/12/2016 7:00am UK Regulatory (RNS & others) GlaxoSmithKline (LSE:GSK) Intraday Stock Chart Today : Tuesday 20 December 2016 TIDMGSK RNS Number : 2967S GlaxoSmithKline PLC 19 December 2016 ViiV Healthcare announces positive ...
 ADVFN UK4 weeks ago ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen  National AIDS Treatment Advocacy Project1 month ago GLAXOSMITHKLINE : ViiV Healthcare launches phase III programme to evaluate a long-acting, injectable HIV treatment regimen  4 Traders2 months ago ViiV starts PhIII LA injectable treatment regimen  Shares Magazine2 months ago
Peoples Pharmacy

Add Strokes to the Scary List of PPI Side Effect…

Proton pump inhibitors like esomeprazole, lansoprazole or omeprazole are the most popular treatments for heartburn and reflux disease. It is estimated that 15 million Americans spend $10 billion on such drugs annually. The FDA considers these ...
 Peoples Pharmacy1 month ago

Valeant: Change Is Good

Fellow contributor Giovanni DiMauro published a bearish take on Valeant Pharmaceuticals (NYSE: VRX ) with which I strongly disagree. I'll start by going over DiMauro's points (between quotes) where I hold a variant view and summarize my bullish take ...
 Seeking Alpha1 month ago Why I Am Reversing My Position Of Valeant Pharmaceuticals  Seeking Alpha1 month ago Valeant Pharmaceuticals: Catching A Falling Knife Safely?  Seeking Alpha2 months ago
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less